539938 — Medico Intercontinental Income Statement
0.000.00%
- IN₹384.80m
- IN₹517.06m
- IN₹960.15m
- 58
- 94
- 25
- 65
Annual income statement for Medico Intercontinental, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | IAS | IAS | IAS | IAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 697 | 743 | 762 | 714 | 960 |
Cost of Revenue | |||||
Gross Profit | 121 | 134 | 139 | 165 | 214 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 649 | 692 | 707 | 654 | 880 |
Operating Profit | 48.1 | 51 | 55.6 | 59.3 | 79.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 35.3 | 42.3 | 49.4 | 54.4 | 69.7 |
Provision for Income Taxes | |||||
Net Income After Taxes | 25.8 | 31 | 36.1 | 39.5 | 50.6 |
Net Income Before Extraordinary Items | |||||
Net Income | 25.8 | 31 | 36.1 | 39.5 | 50.6 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 25.8 | 31 | 36.1 | 39.5 | 50.6 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.93 | 9.54 | 5.61 | 3.95 | 5.06 |
Dividends per Share |